featured
Benefit of Pioglitazone on CVD and Non-Alcoholic Steatohepatitis vs Low Risk of Bladder Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Research and Clinical Practice
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
An Updated Meta-Analysis of Pioglitazone Exposure and Bladder Cancer and Comparison to the Drug's Effect on Cardiovascular Disease and Non-Alcoholic Steatohepatitis
Diabetes Res. Clin. Pract. 2018 Jan 01;135(xx)102-110, MB Davidson, D PanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.